Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

NCT05502458 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

NCT NCT05502458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05502458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor
Lead sponsor
Zhejiang Cancer Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2020
Completion date
August 8, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cells, desflurane adverse reaction, hepatocellular carcinoma, propofol adverse reaction